Performance of a novel up-flow electrocatalytic hydrolysis acidification reactor (UEHAR) coupled with anoxic/oxic system for treating coking wastewater.

In this study, the performance of a novel up-flow electrocatalytic hydrolytic acidification reactor (UEHAR) and anoxic/oxic (ANO2/O2) combined system (S2) was compared with that of a traditional anaerobic/anoxic/oxic (ANA/ANO1/O1) system (S1) for treating coking wastewater at different hydraulic retention time (HRT). The effluent non-compliance rates of chemical oxygen demand (COD) of S2 were 45 %, 35 %, 25 % and 55 % lower than S1 with HRT of 94, 76, 65 and 54 h. The removal efficiency of benzene, toluene, ethylbenzene and xylene (BTEX) in S2 was 10.6 ± 2.4 % higher than that in S1. The effluent concentration of volatile phenolic compounds (VPs) in S2 was lower than 0.3 mg/L. The dehydrogenase activity (DHA) and adenosine triphosphate (ATP) of O2 were enhanced by 67.2 ± 26.3 % and 40.6 ± 14.2 % compared with O1, respectively. Moreover, COD was used to reflect the mineralization index of organic matter, and the positive correlation between COD removal rate and microbial activity, VPs, and BTEX was determined. These results indicated that S2 had extraordinary microbial activity, stable pollutant removal ability, and transcendental effluent compliance rate.

Phase-transition materials derived photonic metamaterials for passively dynamic solar thermal and coldness harvesting.

The rising need for energy to actively heat and cool human-made structures is contributing to the growing energy crisis and intensifying global warming. Consequently, there's a pressing need for a sustainable approach to temperature management that minimizes energy consumption and carbon emissions. The substantial temperature differences between the Sun (approximately 5800 K), Earth (around 300 K), and outer space (about 3 K) offer a unique opportunity for passive thermal regulation on a global scale. Recent research indicates the possibility of addressing this issue through various low-carbon, passive technologies such as solar heating and radiative cooling. However, their practical application is often limited to certain seasons and climatic regions due to their static and single-function nature in managing temperature. In this context, we introduce a concept of phase-change metamaterials that provide passive, dynamic, and adjustable radiative thermal control, suitable for widespread engineering applications. Our designed metafilm comprises a Polydimethylsiloxane (PDMS) layer infused with vanadium dioxide (VO2) nanoparticles, backed by a layer of broadband-reflective silver (Ag). This metafilm exhibits a self-adjusting solar absorptance, shifting from 0.96 to 0.25 at a pivotal temperature while maintaining a nearly constant thermal emittance. We can finely tune the metafilm's optical characteristics by altering the VO2 nanoparticle concentration and PDMS layer thickness. To demonstrate its efficacy in solar thermal management and radiative cooling, we simulate its temperature behavior under various weather conditions.

High cycle fatigue behavior of implant Ti-6Al-4V in air and simulated body fluid.

Ti-6Al-4V implants that function as artificial joints are usually subjected to long-term cyclic loading. To study long-term fatigue behaviors of implant Ti-6Al-4V in vitro and in vivo conditions exceeding 107 cycles, constant stress amplitude fatigue experiments were carried out at ultrasonic frequency (20 kHz) with two different surface conditions (ground and polished) in ambient air and in a simulated body fluid. The initiation mechanisms of fatigue cracks were investigated with scanning electron microscopy. Improvement of fatigue strength is pronounced for polished specimens below 106 cycles in ambient air since fatigue cracks are initiated from surfaces of specimens. While the cycles exceed 106, surface conditions have no effect on fatigue behaviors because the defects located within the specimens become favorable sites for crack initiation. The endurance limit at 108 cycles of polished Ti-6Al-4V specimens decreases by 7% if it is cycled in simulated body fluid instead of ambient air. Fracture surfaces show that fatigue failure is initiated from surfaces in simulated body fluid. Surface improvement has a beneficial effect on fatigue behaviors of Ti-6Al-4V at high stress amplitudes. The fatigue properties of Ti-6Al-4V deteriorate and the mean endurance limits decrease significantly in simulated body fluid.

Can baseline magnetic resonance angiography (MRA) status become a foremost factor in selecting optimal acute stroke patients for recombinant tissue plasminogen activator (rt-PA) thrombolysis beyond 3 hours?

OBJECTIVE: We investigated whether baseline vessel status evaluated by magnetic resonance angiography (MRA) can be the foremost factor to classify acute ischemic stroke patients into subgroups for thrombolytic therapy within 3-6 hours of symptom onset. METHODS: Acute ischemic stroke patients beyond 3 hours after symptom onset were examined by stroke magnetic resonance imaging (MRI) (diffusion- and perfusion-weighted imaging, and MRA) before and after thrombolysis treatment within 24-48 hours. Stroke MRI was used to classify acute ischemic stroke patients into subgroups and select optimal patients for thrombolytic treatment. Clinical scores were compared to determine whether there were significant differences among subgroups. RESULTS: The difference in day 90 modified Rankin scale (mRS) between treated salvageable and untreated salvageable patients with recombinant tissue plasminogen activator (rt-PA) was remarkably statistically significant (p=0.02). Treated salvageable patients had more favorable clinical outcomes as compared with the untreated salvageable patients. Patients who did not have baseline artery occlusion were associated with more favorable clinical outcomes than untreated salvageable patients (p<0.001). The difference between treated salvageable and patients without artery occlusion in 90 day mRS score was not statistically significant (p=0.058). CONCLUSION: Baseline vessel status evaluated by MRA may be used as the first factor ahead of mismatch to categorize acute ischemic stroke patients into subgroups. Patients who do not have initial vessel occlusion may not need thrombolytic therapy.